Capsaicin for acute or chronic non-cancer pain: a review of clinical effectiveness, safety, and cost-effectiveness / Srabani Banerjee, Suzanne McCormack
Generally, acute pain is defined as lasting less than three months, and chronic pain is defined as pain lasting three months or longer. Acute pain includes pain from sprains, strains, and tendonitis; and muscle aches. Chronic pain includes pain associated with osteoarthritis (OA), neuropathic pain (NP), and back pain. There are several treatment options for managing pain; both pharmacological and nonpharmacological options. A variety of pharmacological options such as non-steroidal antiinflammatory drugs (NSAIDs), local anesthetics, tricyclic antidepressants, and capsaicin have been used for pain management. The purpose of this report is to review the clinical effectiveness, safety and cost-effectiveness of capsaicin products for the treatment of acute and chronic non-cancer pain..
Medienart: |
E-Book |
---|
Erscheinungsjahr: |
July 3, 2020 |
---|---|
Erschienen: |
Ottawa: Canadian Agency for Drugs and Technologies in Health ; July 3, 2020 |
Ausgabe: |
Version 1.0. |
Reihe: |
CADTH rapid response report: summary with critical appraisal |
---|
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Banerjee, Srabani [VerfasserIn] |
---|
Links: |
www.ncbi.nlm.nih.gov [teilw. kostenfrei] |
---|
Themen: |
Acute Pain |
---|
Anmerkungen: |
Includes bibliographical references. - Description based on online resource; title from PDF title page (viewed April 14, 2021) |
---|
Umfang: |
1 online resource (1 PDF file (34 pages)) ; illustrations. |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
1773183052 |
---|
LEADER | 01000cam a22002652 4500 | ||
---|---|---|---|
001 | 1773183052 | ||
003 | DE-627 | ||
005 | 20230428011909.0 | ||
007 | cr uuu---uuuuu | ||
008 | 211011s2020 xx |||||o 00| ||eng c | ||
035 | |a (DE-627)1773183052 | ||
035 | |a (DE-599)KEP068720262 | ||
035 | |a (NCBI)9917749003406676 | ||
035 | |a (EBP)068720262 | ||
040 | |a DE-627 |b ger |c DE-627 |e rda | ||
041 | |a eng | ||
100 | 1 | |a Banerjee, Srabani |e verfasserin |4 aut | |
245 | 1 | 0 | |a Capsaicin for acute or chronic non-cancer pain: a review of clinical effectiveness, safety, and cost-effectiveness |c Srabani Banerjee, Suzanne McCormack |
250 | |a Version 1.0. | ||
264 | 1 | |a Ottawa |b Canadian Agency for Drugs and Technologies in Health |c July 3, 2020 | |
300 | |a 1 online resource (1 PDF file (34 pages)) |b illustrations. | ||
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
490 | 0 | |a CADTH rapid response report: summary with critical appraisal | |
500 | |a Includes bibliographical references. - Description based on online resource; title from PDF title page (viewed April 14, 2021) | ||
520 | |a Generally, acute pain is defined as lasting less than three months, and chronic pain is defined as pain lasting three months or longer. Acute pain includes pain from sprains, strains, and tendonitis; and muscle aches. Chronic pain includes pain associated with osteoarthritis (OA), neuropathic pain (NP), and back pain. There are several treatment options for managing pain; both pharmacological and nonpharmacological options. A variety of pharmacological options such as non-steroidal antiinflammatory drugs (NSAIDs), local anesthetics, tricyclic antidepressants, and capsaicin have been used for pain management. The purpose of this report is to review the clinical effectiveness, safety and cost-effectiveness of capsaicin products for the treatment of acute and chronic non-cancer pain. | ||
650 | 2 | |a Chronic Pain |x therapy |0 https://id.nlm.nih.gov/mesh/D059350Q000628 | |
650 | 2 | |a Acute Pain |x therapy |0 https://id.nlm.nih.gov/mesh/D059787Q000628 | |
650 | 2 | |a Capsaicin |x therapeutic use |0 https://id.nlm.nih.gov/mesh/D002211Q000627 | |
650 | 2 | |a Treatment Outcome |0 https://id.nlm.nih.gov/mesh/D016896 | |
650 | 2 | |a Cost-Benefit Analysis |0 https://id.nlm.nih.gov/mesh/D003362 | |
655 | 2 | |a Systematic Review |0 https://id.nlm.nih.gov/mesh/D000078182 | |
700 | 1 | |a McCormack, Suzanne |e verfasserin |4 aut | |
710 | 2 | |a Canadian Agency for Drugs and Technologies in Health, |e MitwirkendeR |4 ctb | |
856 | 4 | 0 | |u https://www.ncbi.nlm.nih.gov/books/NBK564988/ |m X:NCBI |x Verlag |z teilw. kostenfrei |
912 | |a ZDB-193-NCB | ||
912 | |a GBV_ILN_22 | ||
912 | |a ISIL_DE-18 | ||
912 | |a SYSFLAG_1 | ||
912 | |a GBV_KXP | ||
912 | |a SSG-OLC-PHA | ||
912 | |a GBV_ILN_22_i06404 | ||
912 | |a GBV_ILN_40 | ||
912 | |a ISIL_DE-7 | ||
912 | |a GBV_ILN_74 | ||
912 | |a ISIL_DE-354 | ||
912 | |a GBV_ILN_2003 | ||
912 | |a ISIL_DE-25 | ||
912 | |a GBV_ILN_2009 | ||
912 | |a ISIL_DE-180 | ||
912 | |a GBV_ILN_2010 | ||
912 | |a ISIL_DE-15 | ||
951 | |a BO | ||
980 | |2 22 |1 01 |x 0018 |b 3994080169 |h h64 NCBI |y zi06404 |z 21-10-21 | ||
980 | |2 40 |1 01 |x 0007 |b 3994006414 |h OLR-NCB-BOOKSHELF |y xsn |z 21-10-21 | ||
980 | |2 74 |1 01 |x 0354 |b 3999782684 |c 09 |f E-Bibl |d EM 0000 |e --%%-- |j --%%-- |y ze |z 08-11-21 | ||
980 | |2 2003 |1 01 |x DE-25 |b 3995675654 |c 00 |f --%%-- |d --%%-- |e --%%-- |j n |k Elektronischer Volltext - Open Access |y l01 |z 25-10-21 | ||
980 | |2 2009 |1 01 |x DE-180 |b 3987672579 |c 00 |f --%%-- |d --%%-- |e --%%-- |j --%%-- |y l01 |z 11-10-21 | ||
980 | |2 2010 |1 01 |x DE-15 |b 3987762004 |c 00 |f --%%-- |d --%%-- |e --%%-- |j n |k Elektronischer Volltext - Open Access |y l01 |z 11-10-21 | ||
981 | |2 22 |1 01 |x 0018 |r https://www.ncbi.nlm.nih.gov/books/NBK564988/ | ||
981 | |2 40 |1 01 |x 0007 |y Volltext, Open Access |r https://www.ncbi.nlm.nih.gov/books/NBK564988/ | ||
981 | |2 74 |1 01 |x 0354 |r https://www.ncbi.nlm.nih.gov/books/NBK564988/ | ||
981 | |2 2003 |1 01 |x DE-25 |r https://www.ncbi.nlm.nih.gov/books/NBK564988/ | ||
981 | |2 2010 |1 01 |x DE-15 |y Online-Zugriff |r https://www.ncbi.nlm.nih.gov/books/NBK564988/ | ||
985 | |2 22 |1 01 |x 0018 |a h64 ebook | ||
985 | |2 74 |1 01 |x 0354 |a EM 0000 | ||
995 | |2 22 |1 01 |x 0018 |a h64 NCBI | ||
995 | |2 22 |1 01 |x 0018 |a h64 freie Ressource | ||
995 | |2 40 |1 01 |x 0007 |a OLR-NCB-BOOKSHELF |